Growth Metrics

Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $6.0 million.

  • Fulgent Genetics' Depreciation & Amortization (CF) rose 199.32% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 421.86%. This contributed to the annual value of $24.9 million for FY2024, which is 464.75% down from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Depreciation & Amortization (CF) is $6.0 million, which was up 199.32% from $6.1 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Depreciation & Amortization (CF) peaked at $9.8 million during Q3 2022, and registered a low of $1.9 million during Q1 2021.
  • For the 5-year period, Fulgent Genetics' Depreciation & Amortization (CF) averaged around $5.9 million, with its median value being $6.2 million (2024).
  • As far as peak fluctuations go, Fulgent Genetics' Depreciation & Amortization (CF) skyrocketed by 34043.72% in 2021, and later plummeted by 3463.34% in 2023.
  • Fulgent Genetics' Depreciation & Amortization (CF) (Quarter) stood at $3.5 million in 2021, then soared by 180.78% to $9.8 million in 2022, then crashed by 33.35% to $6.5 million in 2023, then dropped by 5.22% to $6.2 million in 2024, then decreased by 2.49% to $6.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $6.0 million in Q3 2025, compared to $6.1 million in Q2 2025 and $5.9 million in Q1 2025.